How Is Spravato Administered? A Supervised Visit Guide
The phrase “self-administered nasal spray” can make Spravato sound like a medication you pick up and use at home. That is not how this treatment works. Self-administration of Spravato nasal spray takes place under a healthcare professional’s direct supervision in a certified healthcare setting. You use the device yourself, while the treatment team guides administration, monitors your response, and decides when it is safe for you to leave.
Knowing the sequence can make your first visit less uncertain. This guide explains what to prepare, what the team checks, and how to ask for help. It supplements—not replaces—the instructions your prescribing clinician gives you.
Before treatment: confirm the plan, not just the appointment time
Spravato contains esketamine and has specific adult depression indications. It is not interchangeable with a compounded ketamine spray. Your evaluation should already have covered why the treatment is being considered, possible benefits, important risks, alternatives, and your medical and psychiatric history.
The current prescribing information requires monitoring for at least two hours after administration because of risks including sedation, dissociation, and respiratory depression. The full visit also includes preparation and a discharge assessment, so ask the center how much time to reserve rather than scheduling around exactly two hours.
Arrange your ride home before treatment. You must not drive or operate machinery until the next day after a restful sleep. Ask the center about its transportation policy, and plan for responsibilities that would be unsafe while your alertness or judgment might be affected.
Prepare a short question list
Before arriving, confirm the clinic’s instructions about food, liquids, and any nasal medications you use. The official medication instructions include specific pre-treatment restrictions; your clinician should explain how they apply alongside your other health needs. Do not independently skip or change a prescription because you are having a treatment session.
Bring an up-to-date list of prescribed medicines, over-the-counter products, supplements, and relevant substance use. Tell the team about recent illness, a new medicine, changes in your mental state, pregnancy or pregnancy plans, and any previous reaction to ketamine or esketamine. These details are part of safe treatment, not a test you can pass by withholding information.
A practical question is: “Is there anything different about my instructions today?” That is particularly useful after a medication change or a missed visit. Written instructions can help you and your support person remember the plan without relying on what you recall after treatment.
Step one: the team checks readiness and explains the process
At the appointment, staff review whether it is appropriate to proceed and check blood pressure. They should explain where you will sit, how monitoring works, what symptoms to report, and how to get their attention. Ask to see the device before beginning if you are worried about coordination or unfamiliar equipment.
There is no need to pretend that you understand. “Please demonstrate that again” and “Can you talk me through one step at a time?” are reasonable requests. Mention problems with vision, hand movement, nasal obstruction, or following spoken instructions so the team can assess what support is needed.
An appointment can be delayed or treatment reconsidered when a clinical concern arises. A change of plan is not a personal failure; the purpose of assessment is to make the decision appropriate for that day.
Step two: administer Spravato nasal spray under supervision
The clinician supplies the prescribed devices and supervises the process. The official instructions describe one spray into each nostril from each device. Under guidance, you breathe in through your nose while fully pressing the plunger, then sniff gently afterward. Staff check delivery and manage the rest periods between devices.
Watch the video: SPRAVATO (esketamine) Instructions for Use Video for TRD & MDD (SPRAVATO official channel)
Do not test-spray or prime a device, add extra sprays, or repeat a step on your own because you are unsure what happened. Tell the clinician if the spray seemed to miss, liquid dripped, you sneezed, or you did not press as expected. The treatment team—not a blog article—should decide what to do next.
The manufacturer’s administration guidance is intended to support this supervised process. You do not need a “stronger” sniff, an intense sensation, or a technique trick to prove you received an effective treatment. Follow the demonstrated instructions rather than trying to optimize absorption independently.
Step three: monitoring after Spravato administration
During observation, staff monitor breathing, including oxygen saturation, and reassess blood pressure and clinical status. You may experience sleepiness, dizziness, nausea, or a changed sense of yourself or your surroundings. These possibilities are reasons for preparation and monitoring, not reasons to assume every unusual feeling is harmless.
Tell staff promptly if you feel unwell, frightened, unusually sleepy, short of breath, or otherwise concerned. Ask for help before standing or walking if you feel unsteady. Do not minimize symptoms because you think reporting them will jeopardize future treatment.
You can ask beforehand what is permitted during observation: quiet music, a support person, an eye covering, or other comfort measures. Policies differ. None of these should interfere with staff checking on you or with your ability to communicate a concern.
Step four: leaving depends on clinical stability
Reaching the two-hour mark does not automatically mean you are ready to leave. A healthcare professional must assess whether you are clinically stable. Observation may need to continue, so build flexibility into transportation and avoid making an inflexible commitment immediately afterward.
Before discharge, confirm whom to contact about a delayed concern and what symptoms require urgent help. Ask for written instructions and your next appointment details. Feeling clearer is not permission to drive that day; the restriction extends until the following day after restful sleep.
For severe trouble breathing, collapse, or another life-threatening emergency after leaving, call 911. For a non-emergency question about your individual reaction, use the clinical contact instructions provided by the treatment center rather than advice from other patients online.
Track treatment progress separately from the session experience
How treatment feels in the chair and whether depression improves are different questions. A useful follow-up note might describe sleep, ability to start everyday tasks, interest in activities, distress, and any adverse effects. Bring changes in suicidal thoughts to clinical attention promptly rather than waiting for a routine review.
Choose one or two personally important goals with your clinician. Examples could include preparing a meal, concentrating during a conversation, or returning to a manageable responsibility. These are discussion examples, not a validated scoring system or a promise of improvement.
For treatment-resistant depression, benefit is assessed after the induction phase to guide further care. Your clinician should explain how appointments, monitoring, and other treatments fit together. Do not alter the schedule independently or judge the entire treatment plan by one unusually good or difficult day.
Discussing treatment with Sophroneo
Sophroneo Behavioral Health & TMS lists Spravato among its mental health services. The practice also provides depression care, allowing a discussion of symptoms and treatment history rather than focusing only on a particular medication.
Sophroneo has locations in Powder Springs and Marietta in the Atlanta area. Contact the practice to ask about an assessment, confirm the treatment location, and request the preparation and transportation instructions relevant to your appointment. Availability and suitability need individual confirmation.
Frequently asked questions
Can I take Spravato home once I am used to it?
No. The supervised-setting requirement is not removed because previous sessions went smoothly. Spravato is administered through its restricted safety program, with monitoring at each treatment visit. A take-home compounded ketamine product is not the same treatment.
What should I do if I think I used the device incorrectly?
Tell the supervising clinician immediately and describe what happened. Do not repeat sprays or make your own correction. The point of supervision is that you can ask for help while the team checks the device and your administration.
Will I need to talk about painful experiences during administration?
Do not assume that a Spravato appointment includes a particular psychotherapy protocol. Ask what clinical support is provided and whether psychotherapy is scheduled separately. A medication visit should not be presented as a guaranteed emotional breakthrough or a requirement to disclose trauma while affected by the medicine.
This article is educational, not personalized prescribing or administration advice. Follow your treatment team’s instructions. In the United States, call or text 988 for emotional crisis support; call 911 for immediate danger or a life-threatening emergency.
Comments